(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202303 | 202203 | % Var | 202303 | 202203 | % Var | 202303 | 202203 | % Var | |
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 2.69 | 19.83 | -86.43 | 4.19 | 19.83 | -78.87 | 4.19 | 19.83 | -78.87 |
| PBIDT | 1.94 | 19.51 | -90.06 | 2.34 | 18.56 | -87.39 | 2.34 | 18.56 | -87.39 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBDT | 1.94 | 19.51 | -90.06 | 2.34 | 18.56 | -87.39 | 2.34 | 18.56 | -87.39 |
| Depreciation | 0.02 | 0.02 | 0.00 | 0.08 | 0.09 | -11.11 | 0.08 | 0.09 | -11.11 |
| PBT | 1.92 | 19.49 | -90.15 | 2.26 | 18.47 | -87.76 | 2.26 | 18.47 | -87.76 |
| TAX | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | 1.93 | 19.49 | -90.10 | 2.26 | 18.47 | -87.76 | 2.26 | 18.47 | -87.76 |
| Equity | 52.39 | 52.39 | 0.00 | 52.39 | 52.39 | 0.00 | 52.39 | 52.39 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: